Propanc Biopharma, Inc. (OTCMKTS:PPCB) Short Interest Up 21.6% in September

Propanc Biopharma, Inc. (OTCMKTS:PPCB) was the target of a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 1,884,500 shares, a growth of 21.6% from the August 31st total of 1,550,100 shares. Based on an average daily trading volume, of 5,637,300 shares, the short-interest ratio is currently 0.3 days.

Propanc Biopharma Stock Performance

OTCMKTS PPCB opened at $0.00 on Monday. Propanc Biopharma has a one year low of $0.00 and a one year high of $0.03.

Propanc Biopharma Company Profile

Propanc Biopharma, Inc, a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. It offers PRP, a formulation lead product that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes.